See every side of every news story
Published loading...Updated

The Goldman Sachs Group Cuts Relay Therapeutics (NASDAQ:RLAY) Price Target to $18.00

Summary by marketbeat.com
The Goldman Sachs Group lowered their price target on Relay Therapeutics from $20.00 to $18.00 and set a "buy" rating for the company in a report on Thursday.

3 Articles

All
Left
Center
1
Right
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

The Registry broke the news in on Friday, February 28, 2025.
Sources are mostly out of (0)

Similar News Topics

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.